BDR Pharmaceuticals
  • Home
    • About BDR
    • CMD Profile
    • News
    • Blogs
    • Our Strengths
    • Facilities
    • Press Release
    • Company Policies
    • CSR Sustainability
    • Mission & Vision
    • Ethical Marketing Division
    • Milestones
    • Global Presence
    • Board of Directors
    About Us
  • Products
    • Innovation & Technology
    • Regulatory
    • Research & Development
    • IPR
    • Quality Policy
    • Contract Manufacturing
    Expertise
    • Culture
    • Job Openings
    Careers
  • Investors
  • Contact
  1. Home
  2. News

News

Innovative Breakthroughs in Pharmaceuticals: News and Updates

news
Indian Pharma Post Apr 03, 2026

Indian Pharma Market growth flat in Feb 2022

Read More
news
LiveMint.com Apr 03, 2026

How post-Covid syndrome affects your quality of life and impact your family

Read More
news
ET Healthworld Apr 03, 2026

BDR looking to buy majority stake in drug plant in Belarus

Read More
news
APN Live News Apr 03, 2026

BDR Pharma expands its most trusted Anti-Cancer brand of Enzalutamide

Read More
news
Medical Dialogues Apr 03, 2026

BDR Pharma Launches Enzalutamide Under The Brand Name BDENZA

Read More
news
Pharmabiz.com Apr 03, 2026

BDR Pharma introduces prostate cancer drug, enzalutamide 160mg strength

Read More
news
India Med Today Apr 03, 2026

BDR Pharma launches enzalutamide in 160 mg strength

Read More
news
Indian Pharma Post Apr 03, 2026

BDR Pharma launches enzalutamide in 160 mg strength

Read More
news
Bio Spectrum Apr 03, 2026

BDR Pharma unveils prostate cancer drug BDENZA in 160 mg capacity

Read More
news
Express Pharma Apr 03, 2026

BDR Pharma launches Bdenza 160 mg for treatment of prostate cancer

Read More
news
Business Standard Apr 03, 2026

BDR Pharma introduces prostate cancer drug with enhanced strength

Read More
news
Financial Express Apr 03, 2026

BDR Pharma launches BDENZA 160 mg for treatment of Prostate Cancer

Read More
news
The Times of India Apr 03, 2026

BDR Pharma introduces prostate cancer drug with enhanced strength

Read More
news
Indian Pharma Post Apr 03, 2026

BDR plans to enter the regulated markets this year: Raheel Shah, Director, BDR Group of Companies

Read More
news
Business Today Apr 03, 2026

WHO recommends anti-viral drug molnupiravir for non-severe COVID-19 patients

Read More
  • ‹
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • ›
Discover Previous
Global Presence
awards-cta
Discover Next
Press Release
certification-cta
footer-logo

BDR is a “niche” player in both global and domestic arena

Company
About BDR Milestones Our Mission & Vision Our Achivements CMD Profile
Expertise
Innovation & Technology Regulatory Research & Development IPR Quality Policy Contract Manufacturing
Quick Links
Home Products News Careers Contact
Registered Office

BDR Pharmaceuticals Internationals Pvt. Ltd. Registered Office, 407/408, Sharda Chambers, New Marine Lines, Mumbai 400020, India.

+91-22-40560560
Corporate Office

Grievance officer: Mr. Pawan Srivastava

Ombudsman, 6, Engineering Centre, 9 Mathew Road, Opera House, Mumbai- 400004, India.

+91-22-40560560
ombudsman@bdrpharma.com

Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at the buyer's risk. Products currently covered by valid patents in India are offered for R&D purpose in accordance with Section 107(A) of the Patents Act, 1970.

© BDR Pharmaceuticals International Pvt. Ltd, All Rights Reserved. Designed By Ideamagix.

Terms & Conditions | Privacy Policy

  • Home
  • About Us
    • Overview
    • Our Strengths
    • Achievements
    • CSR Sustainability
    • Milestones
    • CMD Profile
    • Facilities
    • Mission & Vision
    • Global Presence
    • News
    • Press Release
    • Ethical Marketing Division
    • Board Of Directors
    • Blogs
    • Company Policies
  • Products
  • Expertise
    • Innovation & Technology
    • Regulatory
    • Research & Development
    • IPR
    • Quality Policy
    • Contract Manufacturing
  • Careers
    • Culture
    • Job Openings
  • Investors
  • Contact